- TRADE NAMES: Bretylate; Critifib
- INDICATIONS: Ventricular tachycardia and fibrillation
- CLASS: Antiarrhythmic class III
- HALF-LIFE: 4–17 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Arsenic, Astemizole, Ciprofloxacin, Enoxacin, Gatifloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Quinolones, Sparfloxacin
Please login to view the rest of this drug profile.
Page last updated 07/31/2023